Guest edited by Prof Milen I. Georgiev and Prof Ruibing Wang
<Pharmacology and Applications of Chinese Materia Medica> is the world’s first, outstanding book of Chinese medicine published globally in both Chinese and English (hereinafter referred to as: the book), which has reflected the modern research and clinical application progress of Chinese medicine, one of the most valuable Chinese culture treasures, with the concepts, methods and languages of pharmacology, chemistry and biomedical sciences. The book was initially edited by a team led by one of the most famous pharmacologists in China, Professor Yusheng Wang. The Chinese version was published in China by the People's Medical Publishing House (the first edition in 1983; second edition in 1998); The English version was published overseas by World Scientific Publishing House in 1986. Since the book was published more than 30 years ago, it has become one of the most famous books published globally in both Chinese and English to explain and reflect the forefront of traditional medicine research and clinical applications with modern biomedical methods and techniques. When the second Chinese edition was published in 1998, Mr. Wenkang Zhang, the back-then Minister of Health, China, inscribed for the book "Inherit with care, Innovate with courage, Promote and develop the nation’s outstanding culture", commending that the book had made significant contributions to Chinese medicine culture, science and technology.
In order to continue this outstanding tradition, and to update the title with the most recent research and clinical discoveries in the area of Chinese medicine and traditional medicine, we are organizing this thematic series "Pharmacology and applications of Chinese medicine" in the journal Chinese Medicine. We cordially invite outstanding review contributions to this thematic series. We welcome submissions from all areas of Chinese medicine spanning from fundamental pharmacology study to clinical applications of both traditional and modern Chinese medicine. Potential topics may include but are not limited to:
- Basic characteristics of Chinese medicine or traditional medicine
- Advances and perspectives of chemical research in Chinese medicine
- Advances and perspectives of quality evaluation of Chinese medicine
- Advances and perspectives of pharmacology of Chinese medicine
- Advances and perspectives of pharmacokinetics of Chinese medicine
- Advances and perspectives of pharmaceutics of Chinese medicine
- Advances in clinical application of Chinese medicine
- Advances and perspectives of safety and adverse effects of Chinese medicine
- Analysis of Chinese medicine registrations and markets
Only concise review articles will be accepted.
Manuscripts should be approximately 5,000-6,000 words (body of text) with an abstract of no more than 300 words (unreferenced), 3-6 total figures and/or tables (additional figures and/or tables can be submitted as supplementary material), and no more than 100 references.
Keywords: provide a list of 4-6 keywords separated by semicolons.
References: Include only those references that are actually cited in your manuscript and cite all references in the text.
For other general formatting guidelines and reference format, please refer to the submission guidelines of Chinese Medicine.
The deadline for submission is October 31st, 2018. To submit your manuscript, please use our online submission system, and indicate in your cover letter that you would like the manuscript to be considered for this thematic series.
As the thematic series is financially supported by Macao Foundation and International Society of Chinese Medicine, the publication fee will be waived for each article accepted for publication in the thematic series. If you are interested in submitting to this thematic series, please send your request for a submission code to the editorial office (firstname.lastname@example.org) along with your manuscript title and abstract before submission, to make sure the APC waiver is properly processed. The grant of waiver will depend on editorial decision.